Exponent (EXPO) Form 144: 1,595 Restricted Shares to Be Sold via Morgan Stanley

Rhea-AI Filing Summary

This Form 144 filed for Exponent Inc (EXPO) notifies of a proposed sale under Rule 144 of 1,595 common shares with an aggregate market value of $112,671.76, to be executed through Morgan Stanley Smith Barney LLC with an approximate sale date of 08/12/2025. The filing identifies the securities as restricted stock acquired in two tranches: 833 shares on 03/12/2021 and 762 shares on 03/12/2025.

The notice reports 50,501,135 shares outstanding, making the proposed sale represent a vanishingly small portion of the company (roughly 0.003% of outstanding shares). No securities were reported sold by the filer in the past three months. The document is a routine insider sale notice and provides transparent transactional detail but no new operational or financial information about the company.

Insights

Securities Analyst

TL;DR: Small insider sale disclosed; amount is immaterial to EXPO's market capitalization and unlikely to affect valuation.

The Form 144 shows a proposed sale of 1,595 shares valued at $112,671.76, executed through Morgan Stanley on or about 08/12/2025. Compared with 50,501,135 shares outstanding, the transaction is negligible in scale. The securities were restricted stock from 03/12/2021 and 03/12/2025, consistent with vesting or similar compensation events. From a market-impact perspective this is routine disclosure and carries a neutral informational value for investors.

Corporate Governance Expert

TL;DR: Filing demonstrates compliance with Rule 144 and internal reporting; no governance red flags apparent.

The notice includes required representations about material information and indicates no recent sales by the filer in the prior three months. Acquisition dates and the broker are disclosed, supporting transparency. Given the immaterial size of the proposed sale relative to outstanding shares, there is no evident governance concern or signal of insider-driven liquidity pressure. The filing reads as a standard, compliant disclosure.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1595	112671.76	50501135	08/12/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/12/2021	Restricted Stock	Issuer			833	03/12/2021	Not Applicable
Common	03/12/2025	Restricted Stock	Issuer			762	03/12/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the EXPO Form 144 disclose?

The filing notifies a proposed insider sale under Rule 144 of 1,595 common shares valued at $112,671.76, to be sold via Morgan Stanley.

How many EXPO shares are proposed for sale and what is the value?

The notice lists 1,595 shares with an aggregate market value of $112,671.76.

When is the approximate sale date in the EXPO Form 144?

The approximate date of sale is listed as 08/12/2025.

Who is the broker handling the proposed EXPO sale?

The broker is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York NY 10004.

What were the acquisition dates and nature of the EXPO shares?

The securities were acquired as restricted stock: 833 shares on 03/12/2021 and 762 shares on 03/12/2025.

How material is this proposed sale relative to EXPO's outstanding shares?

With 50,501,135 shares outstanding, the proposed 1,595 shares represent a negligible portion of the company (approximately 0.003%).